| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |